lenalidomide has been researched along with cholecalciferol in 2 studies
| Studies (lenalidomide) | Trials (lenalidomide) | Recent Studies (post-2010) (lenalidomide) | Studies (cholecalciferol) | Trials (cholecalciferol) | Recent Studies (post-2010) (cholecalciferol) |
|---|---|---|---|---|---|
| 3,532 | 725 | 2,850 | 8,234 | 1,425 | 3,471 |
| Protein | Taxonomy | lenalidomide (IC50) | cholecalciferol (IC50) |
|---|---|---|---|
| Vitamin D3 receptor | Homo sapiens (human) | 0.087 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mitani, K | 1 |
| Amiot, M; Brosseau, C; Dousset, C; Le Gouill, S; Maïga, S; Moreau, P; Pellat-Deceunynck, C; Touzeau, C | 1 |
1 review(s) available for lenalidomide and cholecalciferol
| Article | Year |
|---|---|
[Myelodysplastic syndrome].
Topics: alpha Catenin; Antineoplastic Agents; Azacitidine; Cholecalciferol; Cyclosporine; Decitabine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lenalidomide; Myelodysplastic Syndromes; Prognosis; Thalidomide; Vitamin K 2; World Health Organization | 2008 |
1 other study(ies) available for lenalidomide and cholecalciferol
| Article | Year |
|---|---|
Combination of lenalidomide with vitamin D3 induces apoptosis in mantle cell lymphoma via demethylation of BIK.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; bcl-2 Homologous Antagonist-Killer Protein; Cholecalciferol; CpG Islands; Drug Synergism; Humans; Lenalidomide; Lymphoma, Mantle-Cell; Membrane Proteins; Middle Aged; Mitochondrial Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; RNA Interference; RNA, Small Interfering; Thalidomide; Tumor Cells, Cultured | 2014 |